L
Lyell Immunopharma (LYEL)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Lyell Immunopharma (LYEL)
Lyell Immunopharma, Inc is a T cell reprogramming company. The Company offers T cells to cure patients with solid tumors. Its technologies are designed to be applied in a target and agnostic manner to chimeric antigen receptor (CAR), tumor-infiltrati... Read more
- USD8.01
- USD13.80
- USD7.78
- USD53.90
- -13.40%
- 58.41k
- 129M
- 7.65
- -84.90%
Stock News
3 hours ago
Why Skyrocketed Recursion Pharmaceuticals, Inc. (RXRX) Today
Yahoo
6 hours ago
ADP National Employment Report: 37K Private Jobs Added In May
SeekingAlpha
yesterday
Jim Cramer says Nvidia chips could give the U.S. leverage in the trade war with China
CNBC
yesterday
Stablecoin issuer Circle prices IPO at $31 per share, above expected range, ahead of NYSE debut
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
